An owl butterfly is not speedy in flight, but the sight of its wings makes creatures think twice about making it a quick meal. The wing pattern resembles the eye of an owl. This ability to mimic a top ...

CAMBRIDGE, Mass., Sept. 9, 2025 /PRNewswire/ -- Metaphore Biotechnologies, a Flagship Pioneering-founded generative AI drug design company focused on creating a new class of functional antibodies, ...

Third research collaboration signed under strategic partnership between Novo Nordisk and Flagship Pioneering to develop novel treatment approaches for cardiometabolic and rare diseases Collaboration ...

After two years of development at Flagship Pioneering, start-up Metaphore Biotechnologies emerged on May 16 with $50 million of series A funding. It plans to tackle autoimmune and metabolic diseases ...

Metaphore Biotechnologies (“Metaphore”), a Flagship Pioneering company creating new antibody-based medicines, today announced the formation of its Scientific Advisory Board (SAB). The SAB brings ...

Bioplatform innovation company Flagship Pioneering announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative ...

May 9 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs. Danish drugmaker Novo is trying ...

The company's MIMiC™ platform drives unprecedented insights into molecular interactions to design new biomolecules precisely tuned for therapeutic benefit With $50 million in committed capital from ...

Imitation is not just the sincerest form of flattery. When combined with machine learning, molecular mimicry is how Metaphore Biotechnologies designs novel treatments in autoimmune disease, ...

Last year, Daisuke Kawaguchi began his own personal venture into fashion with his label METAPHORE. Having spent close to a decade working under SOPHNET. and its founder Hirofumi Kiyonaga, we asked ...

Novo in January announced research collaborations with two biotech firms Omega Therapeutics and Cellarity, both of which were founded by U.S. investment firm Flagship Pioneering. Danish drugmaker Novo ...